Photodynamic therapy for nevus sebaceus with topical δ-aminolevulinic acid

Archives of Dermatology

Volumn 135, Issue 6, 1999, Pages 637-640

  Dierickx, Christine C ^a   Goldenhersh, M ^b   Dwyer, Peter ^a   Stratigos, Alexander ^a   Mihm, Martin ^a   Rox Anderson, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; LANOLIN ALCOHOL;

ADULT; ARGON LASER; ARTICLE; CASE REPORT; DYE LASER; EMULSION; FEMALE; HISTOPATHOLOGY; HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SEBACEOUS NEVUS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AMINOLEVULINIC ACID; FEMALE; HAMARTOMA; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN DISEASES;

EID: 0033040782     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.6.637     Document Type: Article

References (20)

1. Alper J, Holmes LB, Mihm MC Jr. Birthmarks with serious medical significance: nevocellular nevi, sebaceous nevi and multiple café au lait spots. J Pediatr. 1979; 95:696-670.
2. Conner AE, Bryan H. Nevus sebaceus of Jadassohn. AJDC. 1967;114:626-630.
3. Wilson-Jones E, Heyl T. Naevus sebaceous: a report of 140 cases with special regard to the development of secondary malignant. Br J Dermatol. 1970;82:99-107. Nevus sebaceous is associated with unusual neoplasms: an atlas. Am J Dermatopathol. 1988;10:116.
4. Wilson-Jones E, Heyl T. Naevus sebaceous: a report of 140 cases with special regard to the development of secondary malignant. Br J Dermatol. 1970;82:99-107. Nevus sebaceous is associated with unusual neoplasms: an atlas. Am J Dermatopathol. 1988;10:116.
5. Domingo J, Helwig EB. Malignant neoplasms associated with nevus sebaceous of Jadassohn. J Am Acad Dermatol. 1979;1:545-556.
6. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-157.
7. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 1976;36: 2326-2329.
8. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6:143-148.
9. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14:275-292.
10. Divaris DXG, Kennedy JC, Poittier RH. Phototoxic damage to sebaceous glands and hairfollicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990;136:891-897.
11. Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 1987;47: 3110-3114.
12. van Geel IPJ, Oppelaar H, Marijnissen JPA, et al. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. Radiat Res. 1996; 145:602-609.
13. van der Veen N, De Bruijn HS, Star WM. Photobleaching during and reappearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin. Int J Cancer. 1997;72:110-118.
14. Szeimies RM, Abels C, Fritsch C, et al. Wavelength dependency of photodynamic effects alter sensitization with 5-aminolevulinic acid in vivo and vitro. J Invest Dermatol. 1995;105:672-677.
15. Konig K, Schneckenburger H, Ruck A, et al. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol B. 1993;18:287-290.
16. Gudgin Dickson EF, Pottier RH. On the role of protoporphyrin IX photoproducts in photodynamic therapy. J Photochem Photobiol B. 1995;29:91-93.
17. Martin A, Tope WD, Grevelink JM, Anderson RR. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Dermatol Res. 1995;287:665-674.
18. Warloe T, Peng Q, Heyerdahl J, et al. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinomas. In: 5th International Photodynamic Association Biennial Meeting. Abstract Book of Proceedings of the Society of Photo-optical Instrumentation Engineers. 1995;2371: 226-235.
19. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumors using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol. 1995;133: 282-288.
20. Ortel B, Tanew A, Hönigsmann H. Lethal photosensitization by endogenous porphyrins of PAM cells: modification by desferrioxamine. J Photochem Photobiol B. 1993;17:273-278.